Quantum-Si incorporated

NasdaqGM QSI

Quantum-Si incorporated Current Liabilities for the quarter ending September 30, 2024: USD 15.34 M

Quantum-Si incorporated Current Liabilities is USD 15.34 M for the quarter ending September 30, 2024, a 39.38% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Quantum-Si incorporated Current Liabilities for the quarter ending September 30, 2023 was USD 11.01 M, a -12.93% change year over year.
  • Quantum-Si incorporated Current Liabilities for the quarter ending September 30, 2022 was USD 12.64 M.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
NasdaqGM: QSI

Quantum-Si incorporated

CEO Mr. Jeffrey Alan Hawkins
IPO Date Nov. 13, 2020
Location United States
Headquarters 530 Old Whitfield Street
Employees 159
Sector Health Care
Industries
Description

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Similar companies

SEER

Seer, Inc.

USD 2.29

-1.29%

RNA

Avidity Biosciences, Inc.

USD 27.05

-4.79%

NRIX

Nurix Therapeutics, Inc.

USD 18.60

-2.16%

PRME

Prime Medicine, Inc.

USD 2.70

-2.53%

MNOV

MediciNova, Inc.

USD 1.91

-4.02%

VERV

Verve Therapeutics, Inc.

USD 5.25

-4.54%

HRTX

Heron Therapeutics, Inc.

USD 1.47

-4.54%

BDTX

Black Diamond Therapeutics, Inc.

USD 2.25

-2.60%

HOOK

HOOKIPA Pharma Inc.

USD 1.86

4.49%

NTLA

Intellia Therapeutics, Inc.

USD 9.74

-3.08%

EDIT

Editas Medicine, Inc.

USD 1.14

-1.72%

BEAM

Beam Therapeutics Inc.

USD 23.30

-8.77%

CRBU

Caribou Biosciences, Inc.

USD 1.56

0.65%

ALEC

Alector, Inc.

USD 1.64

-8.38%

ABOS

Acumen Pharmaceuticals, Inc.

USD 1.56

-1.89%

CRSP

CRISPR Therapeutics AG

USD 38.36

-1.26%

StockViz Staff

January 15, 2025

Any question? Send us an email